Abraxis Bought Out

Our San Francisco presenter spoke of a high likelihood of a buyout for Abraxis (NASDAQ: ABII, $74.20) at our SF idea forum in April. The announcement today confirmed his view. ABII is getting acquired by Celgene, with the deal expected to be finalized in Q4. The stock was trading at $51 at the time of the presentation.